Credit Analysis Report: MEDICASE LIMITED

1. Credit Opinion: CONDITIONAL

Reasoning: Medicase Limited demonstrates a positive trajectory in net asset recovery, moving from negative equity (£-27,996 in 2022) to a positive position (£123,977 in 2025). However, this approval is conditional due to significant liquidity concerns. The company operates with an extremely thin cash position (£7,987) against substantial current liabilities (£456,143), creating acute vulnerability to debtor collection delays. The business model—medical-legal reporting for personal injury claims—creates inherent cash flow timing risk, as revenue collection depends on third-party litigation cycles. Credit should only be extended with appropriate covenants and monitoring.

2. Financial Strength

Balance Sheet Summary (FY2025): | Metric | Amount | |--------|--------| | Total Assets | £580,983 | | Total Liabilities | £456,143 | | Net Assets | £123,977 | | Shareholders' Funds | £123,977 | | Share Capital | £100 |

Positive Indicators: - Net assets have recovered significantly from negative territory (£-27,996 in FY2022 to £123,977 in FY2025), representing approximately £152,000 of cumulative profit retention over three years - Total liabilities have been reduced by 44% from their peak (£812,831 in FY2022 to £456,143 in FY2025) - The company carries minimal long-term debt (£1,769) - Gearing is low—secured bank loans total only £12,235 with a fixed and floating charge

Concerning Indicators: - Total assets have contracted from £1.56M (FY2016) to £581K (FY2025)—a 63% decline over the decade, suggesting significant business contraction - Net asset volatility over the period (swinging from £169,404 to negative and back) raises questions about earnings stability - The share capital of £100 is negligible, offering no meaningful equity cushion

Leverage Assessment: Low. The debt-to-equity ratio is approximately 3.7:1 on total liabilities, but bank borrowings are minimal. The primary obligation is trade creditors (£304,797), which likely represents amounts owed to medical professionals for reports completed—a operational feature of this business model rather than traditional leverage.

3. Cash Flow Assessment

Working Capital Position: | Metric | FY2025 | FY2024 | |--------|--------|--------| | Current Assets | £580,983 | £664,573 | | Current Liabilities | £456,143 | £557,068 | | Net Current Assets | £124,840 | £107,505 | | Current Ratio | 1.27x | 1.19x | | Quick Ratio (ex-debtors) | 0.02x | 0.05x |

Critical Concern—Debtor Dependency: Trade debtors of £567,434 represent 97.8% of current assets. This extreme concentration creates material risk: - If even 22% of debtors prove uncollectible, net current assets are eliminated - The quick ratio of 0.02x means the company cannot cover even 2% of its current liabilities without collecting receivables - Cash has declined from £57,303 (FY2023) to £7,987 (FY2025), suggesting cash conversion challenges

Cash Flow Dynamics: The business model creates structural cash flow timing risk. Medical-legal reports are commissioned by solicitors/insurers, with payment typically received only after case settlement or upon agreed reporting milestones. This creates a working capital cycle that can extend significantly.

Creditor Position: - Trade creditors: £304,797 (likely fees owed to medical experts) - Taxes & social security: £103,540 (substantial—suggests either profitability or accumulated obligations) - The reduction in trade creditors from £385,623 (FY2024) to £304,797 (FY2025) indicates active debt reduction

4. Monitoring Points

Key Monitoring Recommendations: 1. Aged debtor analysis should be requested quarterly—understanding the aging profile of £567K in debtors is critical 2. Cash conversion trends—monitor whether the decline from £57K to £8K cash is seasonal or structural 3. Related party transactions—The Independent General Practice Limited holds >75% voting rights; understand intercompany flows 4. Sector headwinds—Personal injury claims reform (whiplash regulations, fixed fees) may impact revenue 5. Filing compliance—Currently good, but monitor for any overdue filings

Additional Considerations

Corporate Structure: The PSC register shows The Independent General Practice Limited (corporate entity with >75% voting rights) alongside three individual shareholders each holding 25-50%. This suggests potential for intercompany transactions that may affect cash flow independence.

Management Quality: The two director-shareholders are both medical professionals (Dr. Longstaffe and Dr. Hughes). The company has maintained filing compliance and has demonstrated discipline in reducing liabilities by £357K over three years. However, the persistent low cash position and high debtor dependency suggests either inadequate treasury management or structural features of the business model.

Business Resilience: As a specialist medical-legal provider with only 2 employees, the business is highly dependent on key individuals. The significant contraction in total assets over the decade (from £1.56M to £581K) suggests either strategic downsizing or market share erosion. The recent improvement in net assets is encouraging but must be viewed against this longer-term decline.